News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Asabys Partners
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead candidate into clinical development in neurological diseases
Healthcare · Access to innovation · Financing
Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6…
Partners - Asabys Partners
Oryzon_AseBio
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
Corporate
All resolutions were approved. Additional resolution to increase capital for up to 100 million…
Partners - Oryzon Genomics
Profesional de laboratorio manipulando máquinas en la instalaciones de Hipra
The European authority HERA visits HIPRA for its productive capacity in the face of future pandemic
Healthcare · Access to innovation · Drug discovery · Industrial biotechnology
The top leadership team from HERA (Health Emergency Preparedness and Response), the European…
Partners - HIPRA HUMAN HEALTH S.L.U.
Diego Pazos Castro, Cancer & Microbiology Research Scientist en Lifesome Therapeutics
#NewAseBioMember | “AseBio constitutes a meeting point and driving force for the main actors of the biotech industry in Spain”
Corporate
Meet Lifesome Therapeutics, our new member. We talked its Diego Pazos Castro, Cancer &…
AseBio - LIFESOME THERAPEUTICS
Juan Basterra, CEO Mikrobiomik
Juan Basterra (Mikrobiomik) | "In the last 10 years, decisive steps have been taken to understand and appreciate the role of our gut microbiota"
Healthcare · Drug discovery · Innovative drugs
Mikrobiomik is working to become the first company globally to market the first biological drug…
AseBio - Mikrobiomik
Una chica apoyada en una pared
Oryzon announces presentation of final data from PORTICO, vafidemstat’s global Phase IIb trial in Borderline Personality Disorder, at the 37th ECNP annual conference
Healthcare · Access to innovation · Rare diseases · Advanced therapies
Seleccionada para presentación oral. La conferencia se celebrará en Milán del 21-23 de septiembre…
Partners - Oryzon Genomics
Evento sobre inteligencia artificial y salud organizado por AseBio y el Ministerio de Sanidad
AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial Intelligence in health data spaces
Healthcare · Access to innovation
The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces,"…
Investigación en biotecnología
Overcoming Challenges in the Current Biotech Landscape
Biotech entrepreneurs have experienced a demanding drug development environment in the last 24…
foto_recurso_medicamentos
Alira Health Publishes a White Paper on the Impact of New European Union Regulations on Advanced Therapy Medicinal Product
Healthcare · Access to innovation · Drug discovery
It provides an overview of the key changes that will impact access to innovative medicines and…